184 related articles for article (PubMed ID: 25313925)
1. Potentiated interaction between ineffective doses of budesonide and formoterol to control the inhaled cadmium-induced up-regulation of metalloproteinases and acute pulmonary inflammation in rats.
Zhang W; Zhi J; Cui Y; Zhang F; Habyarimana A; Cambier C; Gustin P
PLoS One; 2014; 9(10):e109136. PubMed ID: 25313925
[TBL] [Abstract][Full Text] [Related]
2. Protective effects of tiotropium alone or combined with budesonide against cadmium inhalation induced acute neutrophilic pulmonary inflammation in rats.
Zhao S; Yang Q; Yu Z; Lv Y; Zhi J; Gustin P; Zhang W
PLoS One; 2018; 13(2):e0193610. PubMed ID: 29489916
[TBL] [Abstract][Full Text] [Related]
3. Anti-inflammatory effects of formoterol and ipratropium bromide against acute cadmium-induced pulmonary inflammation in rats.
Zhang W; Fievez L; Cheu E; Bureau F; Rong W; Zhang F; Zhang Y; Advenier C; Gustin P
Eur J Pharmacol; 2010 Feb; 628(1-3):171-8. PubMed ID: 19925785
[TBL] [Abstract][Full Text] [Related]
4. Effects of formoterol and ipratropium bromide on repeated cadmium inhalation-induced pulmonary inflammation and emphysema in rats.
Zhang W; Fievez L; Zhang F; Cheu E; Antoine N; Delguste C; Zhang Y; Rong W; Bureau F; Advenier C; Gustin P
Eur J Pharmacol; 2010 Nov; 647(1-3):178-87. PubMed ID: 20826145
[TBL] [Abstract][Full Text] [Related]
5. Effects of budesonide and N-acetylcysteine on acute lung hyperinflation, inflammation and injury in rats.
Jansson AH; Eriksson C; Wang X
Vascul Pharmacol; 2005 Aug; 43(2):101-11. PubMed ID: 15967733
[TBL] [Abstract][Full Text] [Related]
6. Fast beneficial systemic anti-inflammatory effects of inhaled budesonide and formoterol on circulating lymphocytes in asthma.
Rüdiger JJ; Gencay M; Yang JQ; Bihl M; Tamm M; Roth M
Respirology; 2013 Jul; 18(5):840-7. PubMed ID: 23617551
[TBL] [Abstract][Full Text] [Related]
7. Budesonide ameliorates lung function of the cigarette smoke-exposed rats through reducing matrix metalloproteinase-1 content.
Sun J; Zhang P; Zhang B; Li K; Li Z; Li J; Zhang Y; Sun W
Int J Clin Exp Pathol; 2015; 8(5):5137-44. PubMed ID: 26191209
[TBL] [Abstract][Full Text] [Related]
8. Budesonide/formoterol effects on metalloproteolytic balance in TGFbeta-activated human lung fibroblasts.
Todorova L; Gürcan E; Westergren-Thorsson G; Miller-Larsson A
Respir Med; 2009 Nov; 103(11):1755-63. PubMed ID: 19375904
[TBL] [Abstract][Full Text] [Related]
9. Effects of formoterol-budesonide on airway remodeling in patients with moderate asthma.
Wang K; Liu CT; Wu YH; Feng YL; Bai HL; Ma ES; Wen FQ
Acta Pharmacol Sin; 2011 Jan; 32(1):126-32. PubMed ID: 21170080
[TBL] [Abstract][Full Text] [Related]
10. Protective effect of budesonide/formoterol compared with formoterol, salbutamol and placebo on repeated provocations with inhaled AMP in patients with asthma: a randomised, double-blind, cross-over study.
Aalbers R; Boorsma M; van der Woude HJ; Jonkers RE
Respir Res; 2010 May; 11(1):66. PubMed ID: 20509942
[TBL] [Abstract][Full Text] [Related]
11. Additive anti-inflammatory effect of formoterol and budesonide on human lung fibroblasts.
Spoelstra FM; Postma DS; Hovenga H; Noordhoek JA; Kauffman HF
Thorax; 2002 Mar; 57(3):237-41. PubMed ID: 11867828
[TBL] [Abstract][Full Text] [Related]
12. Budesonide/formoterol: a review of its use as maintenance and reliever inhalation therapy in asthma.
McCormack PL; Lyseng-Williamson KA
Drugs; 2007; 67(16):2407-31. PubMed ID: 17983258
[TBL] [Abstract][Full Text] [Related]
13. Budesonide and formoterol inhibit ICAM-1 and VCAM-1 expression of human lung fibroblasts.
Spoelstra FM; Postma DS; Hovenga H; Noordhoek JA; Kauffman HF
Eur Respir J; 2000 Jan; 15(1):68-74. PubMed ID: 10678623
[TBL] [Abstract][Full Text] [Related]
14. Non-pulmonary effects induced by the addition of formoterol to budesonide therapy in patients with mild or moderate persistent asthma.
Centanni S; Carlucci P; Santus P; Boveri B; Tarricone D; Fiorentini C; Lombardi F; Cazzola M
Respiration; 2000; 67(1):60-4. PubMed ID: 10705264
[TBL] [Abstract][Full Text] [Related]
15. Effects of budesonide and formoterol on NF-kappaB, adhesion molecules, and cytokines in asthma.
Wilson SJ; Wallin A; Della-Cioppa G; Sandström T; Holgate ST
Am J Respir Crit Care Med; 2001 Sep; 164(6):1047-52. PubMed ID: 11587995
[TBL] [Abstract][Full Text] [Related]
16. The effects of regular inhaled formoterol and budesonide on preformed Th-2 cytokines in mild asthmatics.
Wallin A; Sandström T; Cioppa GD; Holgate S; Wilson S
Respir Med; 2002 Dec; 96(12):1021-5. PubMed ID: 12477218
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of chlorine-induced pulmonary inflammation and edema by mometasone and budesonide.
Chen J; Mo Y; Schlueter CF; Hoyle GW
Toxicol Appl Pharmacol; 2013 Oct; 272(2):408-13. PubMed ID: 23800689
[TBL] [Abstract][Full Text] [Related]
18. Bronchoprotection in conscious guinea pigs by budesonide and the NO-donating analogue, TPI 1020, alone and combined with tiotropium or formoterol.
Turner Dl; Ferrari N; Ford WR; Kidd EJ; Nevin B; Paquet L; Renzi P; Broadley KJ
Br J Pharmacol; 2012 Oct; 167(3):515-26. PubMed ID: 22563753
[TBL] [Abstract][Full Text] [Related]
19. Repeated cadmium nebulizations induce pulmonary MMP-2 and MMP-9 production and emphysema in rats.
Kirschvink N; Vincke G; Fiévez L; Onclinx C; Wirth D; Belleflamme M; Louis R; Cataldo D; Peck MJ; Gustin P
Toxicology; 2005 Jul; 211(1-2):36-48. PubMed ID: 15863246
[TBL] [Abstract][Full Text] [Related]
20. Acute lung injury induces cardiovascular dysfunction: effects of IL-6 and budesonide/formoterol.
Suda K; Tsuruta M; Eom J; Or C; Mui T; Jaw JE; Li Y; Bai N; Kim J; Man J; Ngan D; Lee J; Hansen S; Lee SW; Tam S; Man SP; Van Eeden S; Sin DD
Am J Respir Cell Mol Biol; 2011 Sep; 45(3):510-6. PubMed ID: 21169556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
